Metabolic & Endocrine Disease Summit (MEDS) Newsletter
Inaugural Medscape Cardiology Newsletter
45th Annual Hawaii Dermatology Seminar
Innovations in Dermatology Newsletter
3rd Annual Perspective in Lung Cancer Care
Psychiatry Update Spring 2023
Innovations in Psychiatry Newsletter
There are no results under this Specialty.
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.
Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.
Consider dose escalation and adding an immunomodulator to overcome the impact of antidrug antibodies in rheumatic disease patients.